Filed in archive
Studies
, Treatment
by Gloria Gamat on April 12, 2006

GlaxoSmithKline's Cervarix® is an experimental vaccine against cervical cancer. A study conducted by a research team from Dartmouth Medical School, USA claims that Cervarix® can protect women against cervical cancer for at least four and a half years and may also provide protection form other viruses that cause cancer.
The report on this study headed by Dr. Diane Harper can be read at the April 6 issue of The Lancet.
Source: Medical News Today
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/19939
Mr Wong
Vote for Cervarix®, Cervical Cancer Vaccine of Long Effectivity:
|
Rating: 8.14 out of 7 vote(s) cast.
|
Response from:
angels
(09/21/06 2:32am)
looking forward to this vaccine
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









